RECRUITING

Improving Diabetes Equity and Advancing Care Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized trial is to determine the optimal combination and sequence of three enhancements for a team-based care model for patients living with diabetes in Chicago. The study aim is to determine optimization of intervention components. Participants will be randomly assigned to diabetes self-management training or remote glucose monitoring. After 6 months, participants will be rerandomized to a subsequent study arm (including a CHW support program) depending on a tailoring variable of change in A1c. Researchers will compare the final 6 study arms to see which combination and sequence of enhancements produces the most improvement in A1c.

Official Title

Improving Diabetes Equity and Advancing Care Study

Quick Facts

Study Start:2023-10-23
Study Completion:2025-03-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06040463

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * A diagnosis of type 1 or type 2 diabetes
  2. * 18+ years of age
  3. * Able to provide consent
  4. * Identify as African American/Black or Latinx
  5. * most recent HbA1c \> 7%,
  6. * Have a smartphone compatible with the Glooko application
  7. * Have completed at least one Center appointment (i.e. current patient)
  8. * Completed at least 3 months of their assigned study condition
  1. * Already an active user of RGM
  2. * Actively working with a CHW
  3. * Diagnosis of gestational diabetes (without type 1 or type 2)
  4. * Has a Power of Attorney
  5. * Be suffering from Stage-V renal disease or undergoing dialysis.
  6. * Be suffering from a severe form of cardiovascular disease (NYHA Class III and IV)

Contacts and Locations

Study Contact

Jackie Jacobs, MPH
CONTACT
7732572553
jackie.jacobs@sinai.org
Helen Margellos-Anast, MPH
CONTACT
7732575259
helen.margellos@sinai.org

Study Locations (Sites)

Mount Sinai Hospital
Chicago, Illinois, 60608
United States

Collaborators and Investigators

Sponsor: Sinai Health System

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-23
Study Completion Date2025-03-31

Study Record Updates

Study Start Date2023-10-23
Study Completion Date2025-03-31

Terms related to this study

Keywords Provided by Researchers

  • implementation science
  • optimization study

Additional Relevant MeSH Terms

  • Diabetes
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2